Emergent BioSolutions | 贷款资金



金融业
股票价格
USD
资产
USD 1.82B
现金及等价物
USD 111.7M
销售成本
USD 381.2M
流动资产
USD 679.5M
流动负债
USD 651.3M
债务
USD 903.2M
股息收益率
0
EBIT
USD -148.1M
EBITDA
USD -113.5M
员工
1.6K
EPS每股收益
USD -0.77
股本和储备
USD 649.3M
销售毛利
USD 10M
债务利息支出
USD 17.9M
贷款资金
USD 446.5M
市值
USD 120.6M
净收入
USD -261.3M
营业费用
USD 555.9M
营业利润
USD -218M
普通股股本
USD 100K
PE价格收益
14.4
税前利润
USD -130.8M
销售收入
USD 276.6M
销售和管理费用
USD 182.8M
股票
USD 328.9M
贸易债权人
USD 112.2M
应收帐款人
USD 290.1M


贷款资金 更改 日
Acadia Pharmaceuticals USD 0 0 2025-03
Akebia Therapeutics USD 47.64M 579K 2025-09
ALKERMES USD 285.82M 639K 2024-09
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
ANI Pharmaceuticals USD 297.68M 310.67M 2025-09
BioMarin Pharmaceutical USD 596.66M 501K 2025-09
Coherus Biosciences USD 294.85M 2.33M 2025-03
Emergent BioSolutions USD 446.5M 1.7M 2023-12
Exact Sciences USD 2.33B 9.34M 2025-09
Glaxosmithkline GBP 20.02B 4.72B 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Ionis Pharmaceuticals USD 28.78M 596.71M 2025-09
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
Lexicon Pharmaceuticals USD 56.11M 2.54M 2025-06
Lonza CHF 4.24B 602M 2024-12
Merck USD 39.97B 6B 2025-09
Moderna USD 610M 584M 2025-12
Myriad Genetics USD 119.5M 60.2M 2025-09
Nektar Therapeutics USD 107.51M 10.35M 2024-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pacira USD 376.72M 1.37M 2025-09
Pfizer USD 57.41B 93M 2025-09
PTC Therapeutics USD 1.84B 298.68M 2025-09
Sanofi EUR 15.72B 2.45B 2025-12
Sarepta Therapeutics USD 1.04B 104.31M 2025-09
United Therapeutics USD 100M 100M 2024-06
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12
Xoma USD 94.38M 7.82M 2025-09


Emergent BioSolutions 贷款资金 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.